Elanco Animal Health (ELAN) Receivables - Net (2017 - 2026)

Elanco Animal Health has disclosed Receivables - Net across 10 years of filings, most recently posting $1.1 billion for Q1 2026.

• Receivables - Net for Q1 2026 came in at $1.1 billion, up 11.75% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.1 billion (up 11.75% YoY), and the FY2025 annual result was $873.0 million, up 8.45% from the prior year.
• Receivables - Net came in at $1.1 billion for Q1 2026 at Elanco Animal Health, up from $873.0 million in the prior quarter.
• In the past five years, Receivables - Net ranged from a high of $1.1 billion in Q1 2026 to a low of $797.0 million in Q4 2022.
• The 5-year median for Receivables - Net is $916.0 million (2022), against an average of $925.6 million.
• Across the five-year window, Receivables - Net dropped 14.15% in 2022 and advanced 13.31% in 2023, its largest moves.
• Elanco Animal Health's Receivables - Net stood at $797.0 million in 2022, then grew by 5.65% to $842.0 million in 2023, then fell by 4.39% to $805.0 million in 2024, then gained by 8.45% to $873.0 million in 2025, then advanced by 24.17% to $1.1 billion in 2026.
• The last three Receivables - Net figures came in at $1.1 billion (Q1 2026), $873.0 million (Q4 2025), and $894.0 million (Q3 2025), per Business Quant data.